Format

Send to

Choose Destination
Diabetes Res Clin Pract. 2016 Aug;118:77-8. doi: 10.1016/j.diabres.2016.06.004. Epub 2016 Jun 16.

Recurrent euglycemic diabetic ketoacidosis after discontinuation of sodium-glucose cotransporter 2 inhibitor.

Author information

1
Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, United States. Electronic address: maraka.spyridoula@mayo.edu.
2
Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, United States. Electronic address: Kearns.Ann@mayo.edu.
3
Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, United States. Electronic address: Kittah.Nana@mayo.edu.
4
Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, United States; Division of Endocrinology, Department of Medicine, National University of Ireland, Galway, Ireland. Electronic address: derek.okeeffe@gmail.com.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center